共 69 条
[1]
Poveda A(2007)Update in the management of ovarian and cervical carcinoma Clin Transl Oncol 9 443-451
[2]
Salazar R(2005)Endogenous hormones and ovarian cancer:Epidemiology ad current hypotheses Cancer Epidemiol Biomark Prev 14 98-107
[3]
del Campo JM(2000)Ovarian cancer: epidemiology, biology, and prognostic factors Semin Surg Oncol 19 3-10
[4]
Mendiola C(2004)Cancer of the ovary N Engl J Med 351 2519-2529
[5]
Cassinello J(1991)Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer Gynecol Oncol 40 103-106
[6]
Ojeda B(1983)St. John ER, Jenison E, Niloff JM, Lazarus H, et al. A radio immunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer N Engl J Med 309 883-887
[7]
Lukanova A(1989)The CA125 tumour-associated antigen: a review of the literature Hum Reprod 4 1-12
[8]
Kaaks R(2008)The early detection of ovarian cancer: From traditional methods to proteomics. Can we really do better than serum CA-125? Am J Obstet Gynecol 99 215-223
[9]
Holschneider CH(2003)Optimizing primary chemotherapy in ovarian cancer Hematol Oncol Clin North Am 17 957-968
[10]
Berek JS(1998)Clinical characteristics of clear cell carcinoma of the ovary Gynecol Oncol 70 255-258